IP Library Granted Patent US 10,918,102
Granted Patent B2
US 10,918,102 · App. 15/125,918 · Granted Feb 16, 2021

Devices and methods to improve and assess viability of human livers

Inventors: Mustafa Korkut Uygun (Boston, MA); Bote G. Bruinsma (Amsterdam, NL); Maria-Louisa Izamis (Eindhoven, NL)
Assignee: The General Hospital Corporation
A01N1/0247A01N1/0226
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,918,102
App. No.
15/125,918
Granted
Feb 16, 2021
Kind
B2
Abstract

The present invention relates to organ perfusion systems that can be used at room temperature. The organ perfusion systems do not comprise a temperature controller. In some embodiments, the organ perfusion systems do not comprise a cleaning device for cleaning the perfusion fluid. The perfusion fluid can comprise Williams' medium E. The organ perfusion systems can be portable and can be used to preserving an organ, preventing ischemic damage in an organ, or recovering an ischemically damaged organ.

Claims (26)

1. An organ perfusion system operating at room temperature, the system comprising

an organ preservation container configured to encase an organ removed from a subject and store a perfusion fluid, whereby the organ is at least partially immersed in the perfusion fluid;

a fluidic circuit system having a first end connected to the perfusion fluid stored in the organ preservation container and a second end connected to the organ, the fluidic circuit system configured to draw the perfusion fluid through the first end and perfuse the organ with the perfusion fluid, and wherein the organ perfusion system does not comprise a temperature controller,

wherein the fluidic circuit system comprises one or more components,

wherein at least one of the one or more components is at least partially immersed in the perfusion fluid,

wherein the organ comprises a first blood vessel and a second blood vessel, and the fluidic circuit system comprises: (a) a first fluidic circuit connected to the first blood vessel and configured to flow a first perfusion fluid through the first blood vessel; and (b) a second fluidic circuit connected to the second blood vessel and configured to flow a second perfusion fluid through the second blood vessel, and

wherein the first fluidic circuit and the second fluidic circuit share a common fluidic pathway.

2. The organ perfusion system of claim 1 , wherein the organ perfusion system does not comprise a cleaning device for cleaning the perfusion fluid.

3. The organ perfusion system of claim 1 , wherein the organ perfusion system is portable.

4. The organ perfusion system of claim 1 , wherein the fluidic circuit system comprises a pressure sensor configured to measure a pressure of the perfusion fluid flowing towards the organ.

5. The organ perfusion system of claim 4 , wherein the fluidic circuit system comprises a pump configured to control a pressure of the perfusion fluid as a function of a measurement of the pressure sensor.

6. The organ perfusion system of claim 1 , wherein the fluidic circuit system comprises an oxygenator configured to increase oxygen level in the perfusion fluid flowing towards the organ.

7. The organ perfusion system of claim 1 , wherein the fluidic circuit system comprises a bubble-removing device configured to remove bubbles from the perfusion fluid flowing towards the organ.

8. The organ perfusion system of claim 1 , wherein the organ is selected from the group consisting of liver, pancreas, kidney, spleen, heart, lung, and a vascular composite tissue that can be cannulated for perfusion.

9. The organ perfusion system of claim 1 , wherein the perfusion fluid is a rich and defined medium.

10. The organ perfusion system of claim 1 , wherein the perfusion fluid comprises Williams' medium E.

11. The organ perfusion system of claim 1 , wherein the perfusion fluid further comprises insulin, one or more antibiotics, hydrocortisone, or any combinations thereof.

12. The organ perfusion system of claim 1 , wherein the perfusion fluid does not comprise red blood cells.

13. The organ perfusion system of claim 1 , further comprising a second container connected to the organ and configured to collect a product produced by the organ.

14. A method of preserving an organ, the method comprising connecting the organ to the organ perfusion system of claim 1 to perfuse the organ.

15. A method of preventing ischemic damage in an organ, the method comprising connecting the organ to the organ perfusion system of claim 1 to perfuse the organ.

16. The organ perfusion system of claim 1 , wherein the organ comprises a portal vein and an artery, and the fluidic circuit system comprises: (a) a first fluidic circuit connected to the portal vein and configured to flow a first perfusion fluid through the portal vein; and (b) a second fluidic circuit connected to the artery and configured to flow a second perfusion fluid through the artery, and wherein the first fluidic circuit and the second fluidic circuit share a common fluidic pathway.

17. The organ perfusion system of claim 16 , wherein the first fluidic circuit is independently controlled from the second fluidic circuit.

18. The organ perfusion system of claim 16 , wherein a pressure of the first perfusion fluid is in the range of 1-10 mmHg.

19. The organ perfusion system of claim 16 , wherein a pressure of the second perfusion fluid is in the range of 20-120 mmHg.

20. The organ perfusion system of claim 16 , wherein the first fluidic circuit and the second fluidic circuit share an oxygenator, a bubble-removing device, or a pressure sensor.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 11, 2024
From: MASSACHUSETTS GENERAL HOSPITAL; MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 069202/0269 →
CONFIRMATORY LICENSE Recorded Jun 21, 2022
From: MASSACHUSETTS GENERAL HOSPITAL
To: UNITED STATES GOVERNMENT
Reel/Frame 060257/0231 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2020
From: UYGUN, MUSTAFA KORKUT; BRUINSMA, BOTE G.; IZAMIS, MARIA-LOUISA
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 053361/0509 →
Continuity (2)
Provisional Application 61952461 · Mar 13, 2014
Related Publication 20170000110A1 · Jan 5, 2017
Cited By (22)
US 1,087,382 US 12,245,585 US 12,245,586 US 12,279,610 US 12,310,357 US 12,329,150 US 12,342,810 US 12,357,533 US 12,369,576 US 12,410,408 US 12,485,064 US 12,543,729 US 12,557,806 US 12,564,187 US 12,610,943 US 12,616,191 US 12,628,818 US 12,635,685 US 12,653,180 US 12,660,813 US 12,709,740 US 12,721,783